Skip to main content
Premium Trial:

Request an Annual Quote

MicroGenDx Acquires Sequencing Lab RTL Genomics

NEW YORK — MicroGenDx said on Wednesday that it has acquired next-generation sequencing laboratory RTL Genomics.

Financial terms of the transaction were not disclosed.

MicroGenDx, which provides sequencing- and PCR-based microbial testing for clinical diagnostic applications, said the deal would help expand its capabilities in nonclinical primary research.

MicroGenDx said it has built a reference database of over 50,000 microbial species based on ITS and 16S sequencing and that the addition of RTL will help it create a similar database with whole-genome sequencing.

"Developing a comprehensive reference database for shotgun sequencing is our long-term goal," Eric Rees, MicroGenDx's chief technology officer, said in a statement. "By evaluating and comparing the bioinformatic performance of our clinical and research workflows, we can now expand datasets and refine our software for both much more rapidly."

MicroGenDx and RTL, both based in Lubbock, Texas, were originally divisions of Southwest Regional PCR. They were spun off into separate businesses in 2017.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.